MARY ZAHAU-LOEHNER: Open Payments
NPI 1285685040 · LEES SUMMIT, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$5,782 in 148 payments from 20 companies in 2025. Trend: 2023 $2,130 · 2024 $6,650 · 2025 $5,782
Food & beverage: $4,109Speaker / faculty: $1,596Education: $77
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 9 | $2,284 |
| LEO Pharma Inc. | 8 | $495 |
| UCB, Inc. | 15 | $493 |
| ABBVIE INC. | 26 | $440 |
| Janssen Biotech, Inc. | 11 | $356 |
| Galderma Laboratories, L.P. | 10 | $244 |
| Arcutis Biotherapeutics, Inc. | 10 | $226 |
| PFIZER INC. | 8 | $215 |
| E.R. Squibb & Sons, L.L.C. | 15 | $188 |
| Novartis Pharmaceuticals Corporation | 8 | $184 |
Products named: DUPIXENT, TREMFYA, Bimzelx, ADBRY, SKYRIZI, Zoryve, NEMLUVIO, Sotyktu.
Industry payments across MO — which companies pay providers there.
